• Sign In
  • Sign Up
  • Sign In
  • Sign Up
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
  • Home
  • Cardiology
  • Endocrinology
  • Neurology
  • Nephrology
  • Dermatology
  • Oncology
  • Obstetrics & Gynecology
  • Otolaryngology
Uncategorized

Age-Related Adaptations in Methylglyoxal Detoxification: Insights from Normoglycaemia and Prediabetes

Groundbreaking research from Germany has revealed how the human body

Read More »
Saif Quadri January 30, 2026
EASD 2025

Clustering of Continuous Glucose Monitoring Data Reveals Distinct Phenotypes of Insulin Resistance in Individuals with Overweight and Grade 1 Obesity

Researchers presenting at the 61st Annual Meeting of the European

Read More »
Saif Quadri January 29, 2026
EASD 2025

Transforming Inpatient Glycaemic Management: A System-Wide Approach to Reducing Hyperglycaemia and Hypoglycaemia

Researchers from the University of California Davis have demonstrated how

Read More »
Saif Quadri January 28, 2026
EASD 2025

Impact of Overweight and Obesity on Fasting Insulin Secretion in Men and Women without Diabetes: Effect Sizes and Mechanisms

A comprehensive European study involving over 1,250 healthy adults has

Read More »
Saif Quadri January 27, 2026
EASD 2025

Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids

The research study was presented on Monday, September 15th, 2025

Read More »
Saif Quadri January 23, 2026
EASD 2025

Precision Medicine in Type 2 Diabetes: Targeting GLP1 Receptor Agonist and SGLT-2 Inhibitor Combination Treatment for Kidney Protection

The comprehensive study was presented on Monday, September 15th, 2025

Read More »
Saif Quadri January 22, 2026
EASD 2025

Sustained Impact of Dapagliflozin on Epicardial Fat Thickness in Type 2 Diabetes: Insights from the DAPAHEART 4-Year Experience

The groundbreaking study was presented on Monday, September 15th, 2025

Read More »
Saif Quadri January 20, 2026
EASD 2025

Achievement of Target CGM Metrics in People with Type 1 Diabetes Treated with Zimislecel (VX-880) in the FORWARD Study

The trial study was presented on Tuesday, September 16th, 2025

Read More »
Saif Quadri January 13, 2026
EASD 2025

Bridging the Gaps in Diabetic Ketoacidosis Management: Real-World Experience of Protocol Adherence and Outcomes in a Major UK Centre

The research study was presented on Tuesday, September 16th, 2025

Read More »
Saif Quadri January 12, 2026
EASD 2025

Overweight, Obesity, and Glycemic Control: Iinsights from the T1D Exchange Registry

The comprehensive study was presented on Tuesday, September 16th, 2025

Read More »
Saif Quadri January 9, 2026
EASD 2025

Obesity and Overweight Prevalence in Patients with Type 1 Diabetes: Data from Czech Registry DiaPanther

The comprehensive study was presented on Tuesday, September 16th, 2025

Read More »
Saif Quadri January 5, 2026
EASD 2025

Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oatfiber Supplementation in Type 2 Diabetes Patients: The Randomised-Controlled NIMROD Study

The trial study was presented on Monday, September 15th, 2025

Read More »
Saif Quadri January 2, 2026
« Prev Page1 Page2 Page3 … Page5 Next »
Latest Conferences
  • Age-Related Adaptations in Methylglyoxal Detoxification: Insights from Normoglycaemia and Prediabetes
  • Clustering of Continuous Glucose Monitoring Data Reveals Distinct Phenotypes of Insulin Resistance in Individuals with Overweight and Grade 1 Obesity
  • Transforming Inpatient Glycaemic Management: A System-Wide Approach to Reducing Hyperglycaemia and Hypoglycaemia
  • Impact of Overweight and Obesity on Fasting Insulin Secretion in Men and Women without Diabetes: Effect Sizes and Mechanisms
  • Mortality, Kidney, and Safety Outcomes with SGLT-2 Inhibitors vs DPP4 Inhibitors in Patients with Type 2 Diabetes Treated with Systemic Glucocorticoids
Societies
  • ACC: American College of Cardiology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • BAD: British Association of Dermatologists
  • ERA EDTA: European Renal Association – European Dialysis and Transplant Association
  • ESC: European Society of Cardiology
  • ISN: International Society of Nephrology
  • WCPD: World Congress of Pediatric Dermatology
  • AHA: American Heart Association
  • AAD: American Association of Dermatology
  • AACE: American Association of Clinical Endocrinology
  • ADA: American Diabetes Association
  • ASN: American Society of Nephrology
  • ISN: International Society of Nephrology
  • IASP: International Association for the Study of Pain
  • SCAI: Society for Cardiovascular Angiography and Interventions
  • AAO-HNS: American Academy of Otolaryngology–Head and Neck Surgery
Speciality
  • Cardiology
  • Endocrinology
  • Nephrology
  • Neurology
  • Dermatology
  • Obstetrics & Gynecology
  • Pain
  • Respiratory
  • Otolaryngology
Tags
AACE ACC ADA AHA ASN BAD ERA ESC ISN ISN-WCN 2021 Kidney Week 2020 SCAI WCPD wcpn

© All rights reserved.